No Data
ResMed, Inspire Medical Fall After Lilly's Zepbound Gains Sleep Apnea Indication
Sector Update: Health Care Stocks Fall Premarket Monday
Does Eli Lilly (NYSE:LLY) Deserve A Spot On Your Watchlist?
Eli Lilly Stock Jumps on FDA Approval of Obstructive Sleep Apnea Treatment
Express News | Resmed Shares Down 5.2% Premarket After U.S. FDA Approves Lilly's Weight-Loss Drug for Sleep Apnea
Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark
MonkeyGee : They must be going crazy. Zepbound for everything. I'm not sure if people realized the concerning side effects.
Stock_Drift OP MonkeyGee : I get it. My dad had some serious side effects from meds late in life but the alternative wasn’t an option and maybe this is different. He really had no choice for a better life if you get that ?